Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

222.27
Delayed Data
As of 4:02pm ET
 -1.48 / -0.66%
Today’s Change
184.50
Today|||52-Week Range
256.80
+5.84%
Year-to-Date
Here's Where I'm Adding
10:53am / TheStreet.com - Paid Partner Content
The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)
Aug 16 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rock...
9:07am / Zacks.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Top Analyst Reports for Allergan, Ecolab & Exelon
Aug 22 / Zacks.com - Paid Partner Content
Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices
Aug 16 / TheStreet.com - Paid Partner Content
Will Conatus Key Candidate Emricasan Drive Long-Term Growth?
Aug 21 / Zacks.com - Paid Partner Content
Pressing AGN Again
Aug 16 / TheStreet.com - Paid Partner Content
My Observations and Takeaways
Aug 21 / TheStreet.com - Paid Partner Content
Teva Is Cheap, Not Dead
Aug 16 / TheStreet.com - Paid Partner Content
Today's Trades
Aug 21 / TheStreet.com - Paid Partner Content
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content
Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain
Aug 17 / TheStreet.com - Paid Partner Content
Drug industry faces 'tidal wave' of litigation over opioid crisis
Aug 11 / FT.com - Paid Partner Content
PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round
Aug 16 / TheStreet.com - Paid Partner Content
Teva Plunges to 10-Year Low, Credit Rating in Jeopardy
Aug 09 / Zacks.com - Paid Partner Content
Valeant Pharmaceuticals: Cramer's Top Takeaways
Aug 16 / TheStreet.com - Paid Partner Content
Valeant/Teva: lost summer
Aug 08 / FT.com - Paid Partner Content